icd 10 code for metastatic gastric cancer

by Helena Runte 8 min read

Diagnosis codes for LONSURF use in metastatic colorectal cancer 1

ICD-10-CM Description
C16.3 Malignant neoplasm of pyloric antrum
Malignant neoplasm of gastric antrum
C16.4 Malignant neoplasm of pylorus
Malignant neoplasm of prepylorus
Feb 15 2022

Diagnosis codes for LONSURF use in metastatic gastric cancer 1
ICD-10-CMDescription
Malignant neoplasm of gastric antrum
C16.4Malignant neoplasm of pylorus
Malignant neoplasm of prepylorus
Malignant neoplasm of pyloric canal
14 more rows

Full Answer

What are the symptoms of metastatic carcinoma?

Oct 01, 2021 · A primary or metastatic malignant neoplasm involving the stomach. ICD-10-CM C16.9 is grouped within Diagnostic Related Group(s) (MS-DRG v 39.0): 374 Digestive malignancy with mcc; 375 Digestive malignancy with cc; 376 Digestive malignancy without cc/mcc; Convert C16.9 to ICD-9-CM. Code History. 2016 (effective 10/1/2015): New code (first year of non-draft …

What is the survival rate for gastric cancer?

Oct 01, 2021 · C78.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C78.89 became effective on October 1, 2021. This is the American ICD-10-CM version of C78.89 - other international versions of ICD-10 C78.89 may differ. Code Also exocrine pancreatic insufficiency ( K86.81)

What is the prognosis for Stage 4 gastric cancer?

Oct 01, 2021 · C16.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C16.1 became effective on October 1, 2021. This is the American ICD-10-CM version of C16.1 - other international versions of ICD-10 C16.1 may differ.

How to code metastatic cancer?

C7A.092) Clinical Information A primary or metastatic malignant neoplasm involving the stomach. Codes C16 Malignant neoplasm of stomach C16.0 Malignant neoplasm of cardia C16.1 Malignant neoplasm of fundus of stomach C16.2 Malignant neoplasm of body of stomach C16.3 Malignant neoplasm of pyloric antrum C16.4 Malignant neoplasm of pylorus

image

How do you code metastatic cancer?

Code C80. 0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.Dec 3, 2018

What is the ICD 10 code for gastric cancer?

C16. 9 - Malignant neoplasm of stomach, unspecified. ICD-10-CM.

What is the ICD 10 code for history of gastric cancer?

Z85. 02 - Personal history of malignant neoplasm of stomach. ICD-10-CM.

What is diagnosis code Z51 11?

11: Encounter for antineoplastic chemotherapy.

What is the ICD-10 code for cholangiocarcinoma?

Cholangiocarcinoma – Bile Duct Cancer (ICD-10: C22)Dec 20, 2014

What are adenocarcinoma cells?

Adenocarcinoma is a type of cancer that starts in mucus-producing (glandular) cells. Many organs have these types of cells and adenocarcinoma can develop in any of these organs.

What is the ICD-10 code for chemotherapy?

11.

What is the correct ICD-10 code for thrombocytopenia?

ICD-10 | Thrombocytopenia, unspecified (D69. 6)

What is the ICD-10 code for Transaminitis?

R74.0ICD-10-CM Code for Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] R74. 0.

What is DX code Z51 12?

Encounter for antineoplastic immunotherapy2022 ICD-10-CM Diagnosis Code Z51. 12: Encounter for antineoplastic immunotherapy.

What is admin code 96413?

Code 96413 (chemotherapy administration, intravenous infusion technique; up to one hour, single or initial substance/drug) would be used to report the first 90 minutes of the infusion.Nov 9, 2018

What is the ICD-10-CM code for immunotherapy?

12.

What is the code for a primary malignant neoplasm?

A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.

What organs are affected by metastasis?

Metastasis to digestive organs. Secondary malignant melanoma of pancreas. Secondary malignant melanoma of pancreas from eye. Secondary malignant neoplasm of esophagus. Secondary malignant neoplasm of gallbladder. Secondary malignant neoplasm of pancreas. Secondary malignant neoplasm of spleen.

What chapter is functional activity?

Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]

What is the code for a primary malignant neoplasm?

A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.

What chapter is functional activity?

Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]

What is a code title?

Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes.

What is a type 2 exclude note?

A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code ( C16) and the excluded code together. malignant carcinoid tumor of the stomach (.

What is the Z85 code for a primary malignancy?

When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.

What is the code for a malignant neoplasm?

Assign first the appropriate code from category T86.-, Complications of transplanted organs and tissue, followed by code C80.2, Malignant neoplasm associated with transplanted organ. Use an additional code for the specific malignancy.

What is the ICd-10 guidelines?

These guidelines, developed by the Centers for Medicare and Medicaid Services ( CMS) and the National Center for Health Statistics ( NCHS) are a set of rules developed to assist medical coders in assigning the appropriate codes. The guidelines are based on the coding and sequencing instructions from the Tabular List and the Alphabetic Index in ICD-10-CM.

When a patient is admitted because of a primary neoplasm with metastasis and treatment is

When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only , the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present .

What is Chapter 2 of the ICD-10-CM?

Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.

When a pregnant woman has a malignant neoplasm, should a code from subcatego

When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.

Can a patient have more than one malignant tumor?

These tumors may represent different primaries or metastatic disease, depending on the site. Should the documentation be unclear, the provider should be queried as to the status of each tumor so that the correct codes can be assigned.

image

Warnings and Precautions

Image
Severe Myelosuppression: LONSURF caused severe and life‑threatening myelosuppression (Grade 3‑4) consisting of neutropenia (38%), anemia (18%), thrombocytopenia (5%), and febrile neutropenia (3%). Two patients (0.2%) died due to neutropenic infection. A total of 12% of LONSURF‑treated patients received gra…
See more on lonsurfhcp.com

Use in Specific Populations

  • Lactation:It is not known whether LONSURF or its metabolites are present in human milk. There are no data to assess the effects of LONSURF or its metabolites on the breast‑fed infant or the effects on milk production. Because of the potential for serious adverse reactions in breast‑fed infants, advise women not to breastfeed during treatment with LONSURF and for 1 day followin…
See more on lonsurfhcp.com

Adverse Reactions

  • Most Common Adverse Drug Reactions in Patients Treated With LONSURF (≥5%):The most common adverse drug reactions in LONSURF‑treated patients vs placebo‑treated patients with mCRC, respectively, were asthenia/fatigue (52% vs 35%), nausea (48% vs 24%), decreased appetite (39% vs 29%), diarrhea (32% vs 12%), vomiting (28% vs 14%), infections (27% vs 16%), a…
See more on lonsurfhcp.com